De novo extended-release Tacrolimus in Kidney Transplant Patients; Is it safe?
Background: This study aimed to investigate whether de novo extended-release tacrolimus (ERT) therapy is safe in kidney recipients. Methods: The study was single-center, retrospective, and included a total of 57 patients, including 30 patients in the ERT group (Group 1) and 27 patients in the immedi...
Main Authors: | Enes Sarıgedik, Gözde Çakırsoy Çakar, Zafer Ercan, Kenan Evren Öztop, Musa Pınar, Hamad Dheir, Necattin Fırat, Mahmud İslam |
---|---|
Format: | Article |
Language: | English |
Published: |
Sakarya University
2023-09-01
|
Series: | Sakarya Tıp Dergisi |
Subjects: | |
Online Access: | https://dergipark.org.tr/tr/download/article-file/3259408 |
Similar Items
-
Effect of tacrolimus in the inner ear of rats
by: Belde Çulhaoğlu, et al.
Published: (2022-03-01) -
Intestinal Permeability in Patients Early after Kidney Transplantation Treated with Two Different Formulations of Once-Daily Tacrolimus
by: Aureliusz Kolonko, et al.
Published: (2023-05-01) -
The effect of tacrolimus conversion from immediate- to extended-release formulation on renal function in renal transplant patients: a meta-analysis
by: Sheng Chao, et al.
Published: (2023-10-01) -
Comparison of the Impact of Pharmacogenetic Variability on the PK of Slow Release and Immediate Release Tacrolimus Formulations
by: Teun van Gelder, et al.
Published: (2020-10-01) -
Erişkin Böbrek Nakli Hastalarında Uzun Etkili Takrolimus Kullanımı, Uzun Dönem Böbrek Ve Hasta Sağkalımı Üzerine Etkisi, Tek Merkez Deneyimi
by: Alaattin Yıldız, et al.
Published: (2023-06-01)